Zerlasiran was found to be well tolerated and no significant safety concerns were observed. Credit: Good dreams - Studio via ...

"AHA 2024: Muvalaplin shows promising Phase II results for elevated serum lipoprotein (a)" was originally created and ...

Eli Lilly LLY announced that its investigational oral, once-daily cholesterol-lowering drug muvalaplin reduced lipoprotein (a) or Lp (a) levels in adults with high risk of cardiovascular events in a ...

Cholesterol is a type of fat in our blood. Our bodies need a small amount of cholesterol to build the structure of cell ...

The Heart & Kidney Health Screening offers no-cost Lp(a) testing as well as screenings for other related metabolism and ...

The review highlights the role of probiotics and synbiotics in enhancing insulin sensitivity and hormonal balance in PCOS, ...

A recent study published in the Journal of Translational Internal Medicine ( reveals significant insights into the broader impact of gastroesophageal reflux disease (GERD) on cardiovascular health.

Sesame seeds are a great source of lignans, compounds that help improve lipid metabolism. They also provide plant sterols and ...

Excessive sedentary time during growth increases systolic blood pressure, while three hours of daily light physical activity ...

Data reveal a strong association between non–high-density lipoprotein (non-HDL) cholesterol to HDL cholesterol ratio and ...

Melbourne researchers are helping expand options for people with high cholesterol that puts them at risk of heart attack or stroke, including world-first drugs for potentially deadly conditions.

Ruth Gimeno, Lilly's group vice president for diabetes and metabolic research, said Eli Lilly is weighing next steps for ...